LG Uplus Stock Advances on AI Data Center Bet: Value LG Uplus is rated Buy as analysts expect AI data center growth via Paju, while earnings rise modestly with low valuation and option value, despite AI execution and compliance risks. 2026년 06월 08일 English
Hanmi Pharmaceutical Stock Pops on GLP 2 News – What Earnings Show Hanmi Pharmaceutical shares rallied on Eli Lilly tech transfer headlines, but latest results show flat revenue and falling operating profit (-9.1% YoY). Bulls cite retained Korea rights and net profit stability; bears warn margins may not recover fast enough to justify the premium valuation. 2026년 06월 05일 English
Korea Aerospace Industries Stock: Earnings Growth Boosts Upside Korea Aerospace Industries looks undervalued as earnings accelerate: revenue +56.3% YoY and operating profit +43.4% YoY, with the stock below analyst targets, though execution and delivery timing remain key risks. 2026년 06월 05일 English
Hanwha Group Shares Re-rate on Earnings Momentum: Key Upside Hanwha Group stock gets a Buy rating as revenue rises 28.9% and net profit jumps 79.5%, supported by improved margins and upside to targets. Key risk: one off net profit gains. 2026년 06월 04일 English
Kakao Stock Rallies on Profit Surge: Labor Risk Ahead Kakao is rated Buy as the stock discounts labor fears ahead of June 10, while latest results show strong momentum: operating profit up 66% YoY, revenue up 11%. 2026년 06월 04일 English
Naver Stock Jumps on Defense AI Shift and Nvidia Deal Naver is rated Buy as revenue grows 16.3% YoY with 16.7% operating margin, but net income fell 32.8% due to cost timing. AI factory and defense AI catalysts drive a buy outlook. 2026년 06월 03일 English
SK Innovation Stock Holds Steady After Earnings Recovery: Key Risk SK Innovation earns a sharp profit rebound, but policy price caps on refining margins and negative ROE keep risk high; consensus is hold (neutral) with wide target range. 2026년 06월 03일 English
Samsung Electro-Mechanics Earnings Jump on AI Parts – Key Outlook Samsung Electro-Mechanics shows strong AI component earnings: revenue up 17.2% YoY, operating profit up 40.0%, net income up 86.3%, supported by MLCC and FC-BGA demand. 2026년 06월 02일 English
Samsung Biologics Shares Rally on Strong Growth: Key Insights Samsung Biologics stays a Buy: despite labor, legal, and quality recall risks, 2026.03 revenue rose 25.8% YoY and operating profit 35.0% YoY, supporting margin resilience and upside. 2026년 06월 02일 English
Hyundai Mobis Stock Repriced Faster: Key Opportunity Hyundai Mobis is rated a Buy as the market rapidly revalues its physical AI and tech/order momentum, despite year over year net profit decline. 2026년 06월 01일 English
